ViroPharma Inc. (NASDAQ:VPHM) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 1.65%
ViroPharma Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 42.31% to $0.15 in the quarter versus EPS of $0.26 in the year-earlier quarter.
Revenue: Decreased 21.21% to $107 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: ViroPharma Inc. reported adjusted EPS income of $0.15 per share. By that measure, the company beat the mean analyst estimate of $0.04. It missed the average revenue estimate of $108.47 million.
Quoting Management: “The early part of 2013 has seen great progress both in our commercial business as well as our development pipeline,” stated Vincent Milano, ViroPharma’s chief executive officer. “In addition to the virologic response data we will share during our conference call today from subjects enrolled into our two maribavir studies, we also expect results from several key programs for Cinryze in the coming quarters such as subcutaneous Cinryze administration, antibody-mediated rejection (NYSE:AMR) in kidney transplant, new uses for C1 INH, as well as additional progress updates with maribavir.”
Key Stats (on next page)…
Revenue increased 0.48% from $106.49 million in the previous quarter. EPS increased to $0.15 in the quarter versus EPS of $-0.06 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.06 to a profit $0.05. For the current year, the average estimate has moved down from a profit of $0.34 to a profit of $0.31 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)